Medical Device Audioconferences
|
|
WEDNESDAY, DECEMBER 17, 2008
|
How State Attorneys General Are Reshaping Pharmaceutical Marketing and Compliance through Fraud Investigations and Settlements
Analysis of Eli Lilly's $62 Million Zyprexa Settlement and Pfizer's $895 million Bextra Settlement
A National Audioconference Sponsored by Harvard Health Policy Review and Rx Compliance Report
|
|
TUESDAY, DECEMBER 9, 2008
|
Advanced Implementation Strategies for a Compliant Grant Process
|
|
THURSDAY, DECEMBER 4, 2008
|
The Lessons of Cephalon's $425 Million Off-Label Settlement: A New Model for Off-label Enforcement
|
|
Monday, September 8, 2008
|
Lessons Learned About Anti-Bribery Foreign Corrupt Practices from Recent Cases
|
|
Wednesday, February 20, 2008
|
How the Recent Landmark $311 Million Device Settlements Will Change Industry Practices
|
|
Wednesday, October 11, 2006
|
Update on the New Medicare Chronic Care Improvement Program
|
|
